» Articles » PMID: 36845856

Reduced Community-acquired Respiratory Virus Infection, but Not Non-virus Infection, in Lung Transplant Recipients During Government-mandated Public Health Measures to Reduce COVID-19 Transmission

Overview
Publisher Wolters Kluwer
Specialty General Surgery
Date 2023 Feb 27
PMID 36845856
Authors
Affiliations
Soon will be listed here.
Abstract

Methods: A single-center, retrospective cohort analysis comparing CARV infection before a statewide stay-at-home order, during the stay-at-home order and subsequent statewide mask mandate, and during 5 mo following the elimination of NPI was performed. All LTx recipients followed by and tested at our center were included. Data (multiplex respiratory viral panels; SARS-CoV-2 reverse transcription polymerase chain reaction; blood cytomegalovirus and Epstein Barr virus polymerase chain reaction; blood and bronchoalveolar lavage bacterial and fungal cultures) were collected from the medical record. Chi-square or Fisher exact tests were utilized for categorical variables. A mixed-effect model was used for continuous variables.

Results: Incidence of non-COVID CARV infection was significantly lower during the MASK period than during the PRE period. No difference was noted in airway or bloodstream bacterial or fungal infections, but cytomegalovirus bloodborne viral infections increased.

Conclusions: Reductions in respiratory viral infections, but not bloodborne viral infections nor nonviral respiratory, bloodborne, or urinary infections, were observed in the setting of public health COVID-19 mitigation strategies, suggesting the effectiveness of NPI in preventing general respiratory virus transmission.

Citing Articles

[Allogeneic hematopoietic stem cell transplantation during the normalization stage of COVID-19 management].

Liu Q, Lin R Zhonghua Xue Ye Xue Za Zhi. 2025; 45(11):977-981.

PMID: 39746688 PMC: 11886683. DOI: 10.3760/cma.j.cn121090-20240817-00308.


Impact of SARS-CoV-2-Related Hygiene Measures on Community-Acquired Respiratory Virus Infections in Lung Transplant Recipients in Switzerland.

Baumann I, Hage R, Gasche-Soccal P, Aubert J, Schuurmans M, The Swiss Transplant Cohort Study Medicina (Kaunas). 2023; 59(8).

PMID: 37629763 PMC: 10456728. DOI: 10.3390/medicina59081473.

References
1.
Oh D, Buda S, Biere B, Reiche J, Schlosser F, Duwe S . Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: Analysis of national surveillance data. Lancet Reg Health Eur. 2021; 6:100112. PMC: 8183189. DOI: 10.1016/j.lanepe.2021.100112. View

2.
Gottlieb J, Schulz T, Welte T, Fuehner T, Dierich M, Simon A . Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study. Transplantation. 2009; 87(10):1530-7. DOI: 10.1097/TP.0b013e3181a4857d. View

3.
Olsen S, Winn A, Budd A, Prill M, Steel J, Midgley C . Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021; 70(29):1013-1019. PMC: 8297694. DOI: 10.15585/mmwr.mm7029a1. View

4.
Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C . A global database of COVID-19 vaccinations. Nat Hum Behav. 2021; 5(7):947-953. DOI: 10.1038/s41562-021-01122-8. View

5.
Shi H, Kim N, Eom S, Kim-Jeon M, Oh S, Moon B . Effects of Non-Pharmacological Interventions on Respiratory Viruses Other Than SARS-CoV-2: Analysis of Laboratory Surveillance and Literature Review From 2018 to 2021. J Korean Med Sci. 2022; 37(21):e172. PMC: 9151990. DOI: 10.3346/jkms.2022.37.e172. View